Wheatgrass molecules systematic review and meta-analysis ( clinical ) Ai Report.docx
Review each suggested relationship below. Accept it if it looks right, edit it to fix a mistake, or reject it if it is wrong. Only accepted relationships will appear on the knowledge map. Rows marked "requires review" are not deleted or blocked - they are just flagged for a closer look.
| Subject | Relationship | Object | Evidence | Evidence Stance | AI Extraction Confidence | Status | Actions |
|---|---|---|---|---|---|---|---|
| chlorophyll Molecule Entity type may require review |
is associated with
Scientific relationship requires review
Expected pattern: |
oral cancer Disease Entity type may require review | Intervention (PICO formulation): In adults with oral cancer or oral potentially malignant disorders (OPMDs), does local delivery (oral strip/film/lozenge) of chlorophyll or chlorophyllin...alter clinical, histologic, or biomarker outcomes | Supports | 95% | Accepted | |
| chlorophyllin Molecule Entity type may require review |
is associated with
Scientific relationship requires review
Expected pattern: |
oral cancer Disease Entity type may require review | Intervention (PICO formulation): In adults with oral cancer or oral potentially malignant disorders (OPMDs), does local delivery (oral strip/film/lozenge) of chlorophyll or chlorophyllin...alter clinical, histologic, or biomarker outcomes | Supports | 95% | Accepted | |
| apigenin Molecule Entity type may require review |
is associated with
Scientific relationship requires review
Expected pattern: |
oral cancer Disease Entity type may require review | Intervention (PICO formulation): In adults with oral cancer or oral potentially malignant disorders (OPMDs), does local delivery...of apigenin (or flavonoid-rich extracts)...alter clinical, histologic, or biomarker outcomes | Supports | 95% | Accepted | |
| quercetin Molecule Entity type may require review |
is associated with
Scientific relationship requires review
Expected pattern: |
oral cancer Disease Entity type may require review | Intervention (PICO formulation): In adults with oral cancer or oral potentially malignant disorders (OPMDs), does local delivery...of quercetin/rutin...alter clinical, histologic, or biomarker outcomes | Supports | 95% | Accepted | |
| rutin Molecule Entity type may require review |
is associated with
Scientific relationship requires review
Expected pattern: |
oral cancer Disease Entity type may require review | Intervention (PICO formulation): In adults with oral cancer or oral potentially malignant disorders (OPMDs), does local delivery...of quercetin/rutin...alter clinical, histologic, or biomarker outcomes | Supports | 95% | Accepted | |
| abscisic acid Molecule Entity type may require review |
is associated with
Scientific relationship requires review
Expected pattern: |
oral cancer Disease Entity type may require review | Intervention (PICO formulation): In adults with oral cancer or oral potentially malignant disorders (OPMDs), does local delivery...of abscisic acid...alter clinical, histologic, or biomarker outcomes | Supports | 95% | Accepted | |
| chlorophyllin Molecule Entity type may require review |
modulates
Scientific relationship requires review
Expected pattern: Molecule/Drug -> MODULATES -> Protein/Pathway |
oxidative-stress markers Biomarker Entity type may require review | Chlorophyllin and chlorophyll derivatives are antioxidants and radioprotective agents that may modulate oxidative-stress—relevant to carcinogenesis | Supports | 85% | Pending | |
| chlorophyll Molecule Entity type may require review |
modulates
Scientific relationship requires review
Expected pattern: Molecule/Drug -> MODULATES -> Protein/Pathway |
oxidative-stress markers Biomarker Entity type may require review | Chlorophyllin and chlorophyll derivatives are antioxidants and radioprotective agents that may modulate oxidative-stress—relevant to carcinogenesis | Supports | 85% | Pending | |
| apigenin Molecule Entity type may require review |
modulates
Scientific relationship requires review
Expected pattern: |
NF-κB Protein Entity type may require review | apigenin, quercetin, and rutin have demonstrated anti-proliferative, pro-apoptotic, anti‑inflammatory and anti‑invasion effects in oral-cancer cellular and animal models, frequently modulating NF-κB, EGFR/STAT3, PI3K/Akt and MMP pathways | Supports | 90% | Accepted | |
| quercetin Molecule Entity type may require review |
modulates
Scientific relationship requires review
Expected pattern: |
NF-κB Protein Entity type may require review | apigenin, quercetin, and rutin have demonstrated anti-proliferative, pro-apoptotic, anti‑inflammatory and anti‑invasion effects in oral-cancer cellular and animal models, frequently modulating NF-κB, EGFR/STAT3, PI3K/Akt and MMP pathways | Supports | 90% | Accepted | |
| rutin Molecule Entity type may require review |
modulates
Scientific relationship requires review
Expected pattern: |
NF-κB Protein Entity type may require review | apigenin, quercetin, and rutin have demonstrated anti-proliferative, pro-apoptotic, anti‑inflammatory and anti‑invasion effects in oral-cancer cellular and animal models, frequently modulating NF-κB, EGFR/STAT3, PI3K/Akt and MMP pathways | Supports | 90% | Accepted | |
| apigenin Molecule Entity type may require review |
modulates
Scientific relationship requires review
Expected pattern: |
STAT3 Protein Entity type may require review | apigenin, quercetin, and rutin have demonstrated anti-proliferative, pro-apoptotic, anti‑inflammatory and anti‑invasion effects in oral-cancer cellular and animal models, frequently modulating NF-κB, EGFR/STAT3, PI3K/Akt and MMP pathways | Supports | 90% | Accepted | |
| quercetin Molecule Entity type may require review |
modulates
Scientific relationship requires review
Expected pattern: |
STAT3 Protein Entity type may require review | apigenin, quercetin, and rutin have demonstrated anti-proliferative, pro-apoptotic, anti‑inflammatory and anti‑invasion effects in oral-cancer cellular and animal models, frequently modulating NF-κB, EGFR/STAT3, PI3K/Akt and MMP pathways | Supports | 90% | Accepted | |
| rutin Molecule Entity type may require review |
modulates
Scientific relationship requires review
Expected pattern: |
STAT3 Protein Entity type may require review | apigenin, quercetin, and rutin have demonstrated anti-proliferative, pro-apoptotic, anti‑inflammatory and anti‑invasion effects in oral-cancer cellular and animal models, frequently modulating NF-κB, EGFR/STAT3, PI3K/Akt and MMP pathways | Supports | 90% | Accepted | |
| apigenin Molecule Entity type may require review |
modulates
Scientific relationship requires review
Expected pattern: |
EGFR Protein Entity type may require review | apigenin, quercetin, and rutin have demonstrated anti-proliferative, pro-apoptotic, anti‑inflammatory and anti‑invasion effects in oral-cancer cellular and animal models, frequently modulating NF-κB, EGFR/STAT3, PI3K/Akt and MMP pathways | Supports | 90% | Accepted | |
| quercetin Molecule Entity type may require review |
modulates
Scientific relationship requires review
Expected pattern: |
EGFR Protein Entity type may require review | apigenin, quercetin, and rutin have demonstrated anti-proliferative, pro-apoptotic, anti‑inflammatory and anti‑invasion effects in oral-cancer cellular and animal models, frequently modulating NF-κB, EGFR/STAT3, PI3K/Akt and MMP pathways | Supports | 90% | Accepted | |
| rutin Molecule Entity type may require review |
modulates
Scientific relationship requires review
Expected pattern: |
EGFR Protein Entity type may require review | apigenin, quercetin, and rutin have demonstrated anti-proliferative, pro-apoptotic, anti‑inflammatory and anti‑invasion effects in oral-cancer cellular and animal models, frequently modulating NF-κB, EGFR/STAT3, PI3K/Akt and MMP pathways | Supports | 90% | Accepted | |
| apigenin Molecule Entity type may require review |
modulates
Scientific relationship requires review
Expected pattern: |
PI3K/Akt Pathway Entity type may require review | apigenin, quercetin, and rutin have demonstrated anti-proliferative, pro-apoptotic, anti‑inflammatory and anti‑invasion effects in oral-cancer cellular and animal models, frequently modulating NF-κB, EGFR/STAT3, PI3K/Akt and MMP pathways | Supports | 90% | Accepted | |
| quercetin Molecule Entity type may require review |
modulates
Scientific relationship requires review
Expected pattern: |
PI3K/Akt Pathway Entity type may require review | apigenin, quercetin, and rutin have demonstrated anti-proliferative, pro-apoptotic, anti‑inflammatory and anti‑invasion effects in oral-cancer cellular and animal models, frequently modulating NF-κB, EGFR/STAT3, PI3K/Akt and MMP pathways | Supports | 90% | Accepted | |
| rutin Molecule Entity type may require review |
modulates
Scientific relationship requires review
Expected pattern: |
PI3K/Akt Pathway Entity type may require review | apigenin, quercetin, and rutin have demonstrated anti-proliferative, pro-apoptotic, anti‑inflammatory and anti‑invasion effects in oral-cancer cellular and animal models, frequently modulating NF-κB, EGFR/STAT3, PI3K/Akt and MMP pathways | Supports | 90% | Accepted | |
| apigenin Molecule Entity type may require review |
modulates
Scientific relationship requires review
Expected pattern: |
MMP Protein Entity type may require review | apigenin, quercetin, and rutin have demonstrated anti-proliferative, pro-apoptotic, anti‑inflammatory and anti‑invasion effects in oral-cancer cellular and animal models, frequently modulating NF-κB, EGFR/STAT3, PI3K/Akt and MMP pathways | Supports | 90% | Accepted | |
| quercetin Molecule Entity type may require review |
modulates
Scientific relationship requires review
Expected pattern: |
MMP Protein Entity type may require review | apigenin, quercetin, and rutin have demonstrated anti-proliferative, pro-apoptotic, anti‑inflammatory and anti‑invasion effects in oral-cancer cellular and animal models, frequently modulating NF-κB, EGFR/STAT3, PI3K/Akt and MMP pathways | Supports | 90% | Accepted | |
| rutin Molecule Entity type may require review |
modulates
Scientific relationship requires review
Expected pattern: |
MMP Protein Entity type may require review | apigenin, quercetin, and rutin have demonstrated anti-proliferative, pro-apoptotic, anti‑inflammatory and anti‑invasion effects in oral-cancer cellular and animal models, frequently modulating NF-κB, EGFR/STAT3, PI3K/Akt and MMP pathways | Supports | 90% | Accepted | |
| chlorophyllin oral strip Formulation Entity type may require review |
contains
Scientific relationship requires review
Expected pattern: |
chlorophyllin Molecule Entity type may require review | Chlorophyllin oral strip, dose/frequency/duration | Supports | 100% | Accepted | |
| quercetin/rutin mucoadhesive film Formulation Entity type may require review |
contains
Scientific relationship requires review
Expected pattern: |
quercetin Molecule Entity type may require review | Quercetin/rutin mucoadhesive film | Supports | 100% | Accepted | |
| quercetin/rutin mucoadhesive film Formulation Entity type may require review |
contains
Scientific relationship requires review
Expected pattern: |
rutin Molecule Entity type may require review | Quercetin/rutin mucoadhesive film | Supports | 100% | Accepted |